Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Italian research links migraine and endometriosis

28.10.2004


Research published today (Thursday 28 October) in Europe’s leading reproductive medicine journal Human Reproduction[1] , has found evidence that women with endometriosis[2] are at higher risk of having migraine.



A team from the University of Genoa in Italy studied 133 women with endometriosis and a control group of 166 women, and found that the prevalence of migraine was significantly higher among the women with endometriosis. Double the number of women in the endometriosis group had migraine compared with the controls.

Although more women with endometriosis had migraine there was no evidence that they had more frequent attacks or more intense pain than the control women who had migraine, and there was no link either with the severity of the endometriosis. However, the researchers did find that age of onset of the migraine was lower in the endometriosis group – 16.4 years as opposed to 21.9.


The study, led by Dr Simone Ferrero, a research fellow and a specialist registrar at the Gynaecologic Department of the University of Genoa, involved women of reproductive age who were undergoing laparoscopy because of infertility, ovarian cysts, benign uterine tumours or pelvic pain. All the women who indicated that they had had at least one headache in the past year were referred to a specialist headache neurologist who performed a clinical interview and classified their headaches according to internationally accepted criteria.

Said Dr Ferrero: "In our population of women with endometriosis a third of the women suffered migraine (and over 13% experienced aura before the onset of the headache), which was significantly higher than we observed in the control group where only 15% suffered from migraine. Although we can’t rule out recall bias, the women with endometriosis reported a lower age at onset than the controls. But, our results did indicate that migraine severity was similar in women with and without endometriosis and was not related to the severity of the endometriosis either."

He said that an estimated 5% of women of reproductive age have endometriosis and somewhere between 15% and 19% of this age group in Europe and the USA have migraine. "In the light of the findings of the study, the two conditions together would be likely to affect around 2 in every 100 women of reproductive age."

The findings did raise some problems and concerns, Dr Ferrero said. "Women with migraine often do not seek appropriate care: for example, it has been reported that more than 4 in 5 patients who consult a physician about their headaches do not see a neurologist or headache specialist. Instead, they consult their primary care practitioner, which, for many women is their gynaecologist. In our study just over 27% of the women with endometriosis and 24% of the control patients had seen a headache specialist and this low rate of migraine assessment had resulted in low rates of specific treatment."

Dr Ferrero said that a gynaecologist must investigate headache carefully in all women with endometriosis but that headache classification should always be performed by a neurologist experienced in diagnosing migraine. "I believe all gynaecologists should always ask their patients with known or suspected endometriosis, ’do you suffer from headaches’? If they do, then a consultation with a neurologist should be advised. When endometriosis and migraine exist together each exerts a significant and independent negative effect on a woman’s quality of life, and pain and the associated symptoms of migraine can be greatly reduced with adequate diagnosis and treatment."

Dr Ferrero said that migraine, particularly migraine with aura, was known to be an independent risk factor for ischaemic stroke in women of reproductive age. Although the absolute risk of stroke was extremely low, it was important that women with endometriosis receiving hormonal treatments should have migraine investigated and diagnosed by a headache specialist as it may be prudent to change the treatment if the migraine developed, or increased, after hormone treatment started. For women needing contraception, combined injectable contraceptives, vaginal rings or progestin-only contraceptives should be the methods considered.

"We don’t really understand the link between the two conditions although some biochemical mediators have been implicated. It is possible that systemic spreading of prostaglandins produced by endometriosis may contribute to migraine and it has also been shown that upregulation or disregulation of nitric oxide synthesis has a role in both migraine and endometriosis. But the association between the two conditions requires further research."

[1] Increased frequency of migraine among women with endometriosis. Human Reproduction.
Doi: 10.1093/humnrep/deh537.

[2] Endometriosis is a painful and distressing condition in which endometrial tissue that under normal circumstances is found only in the lining of the womb, develops outside the uterus and attaches itself to ligaments and organs in the abdominal cavity. This tissue responds to the menstrual cycle as though it were still inside the uterus. The repeated growth and disintegration of endometrial tissue in the abdomen can cause bleeding, pain, inflammation, adhesions and infertility.

Margaret Willson | alfa
Further information:
http://www.mwcommunications.org.uk

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

New drug reduces transplant and mortality rates significantly in patients with hepatitis C

29.05.2017 | Statistics

VideoLinks
B2B-VideoLinks
More VideoLinks >>>